FINAFLEX

Revolution Test

Serving
2 Capsule(s)
Per container
30
Form
capsule-unknown
UPC
689466777154
DSLD
Formula hash
303d4b0df065
Brand context
Catalog
95
products
With avoid flag
27
products
FDA recalls
0
history
CAERS
2
reports
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
1
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

7 active ingredients
IngredientAmount% DV
Vitamin C
vitaminUNII · PQ6CK8PD0R
UL · set5 effects
50 mg84%
Selenium
mineralUNII · H6241UJ22B
UL · set3 effects
200 mcg288%
Testosterone Amplification Blend
Blend (Combination)other
750 mg
Liver Enzyme Regulation Matrix
Blend (Combination)other
300 mg
Cardiovascular Support
Blend (Combination)other
200 mg
Prostate Shield
Blend (Combination)other
160 mg
Letrosterone
TBDother
100 mg
What this product supports · authorized claims

6 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
1
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Gelatin · Magnesium Stearate · Silica · Chlorophyll